Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00048360 | Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults | PHASE3 | COMPLETED | 162 | — | — | Oct 1, 2002 | Jun 1, 2003 | Feb 12, 2013 | 21 | United States |
| Name | Type | Description |
|---|---|---|
| Extended-release bupropion hydrochloride | DRUG | - |
Inclusion criteria: * Patient must be diagnosed with ADHD. Exclusion Criteria: * Patient has a current or past history of seizure disorder, brain injury, anorexia nervosa or bulimia. * Patient has a current diagnosis of Major Depressive Disorder (MDD). * Patient has a current primary diagnosis of...